CD274 and non-small cell lung carcinoma: In EGFR mutant NSCLC, activated EGFR induced PD-L1 expression through PI3K/AKT1 and MAPK signaling pathways (Luo et al., 2021), which is in accord with KEGG pathway analysis (Figure 5).